Clinical efficacy of immune checkpoint inhibitors combined with anlotinib in the treatment of advanced non-small cell lung cancer

doi:10.3969/j.issn.1672-3384.2024.08.012

Qiaojun HONG, Dongdong HAN, Yu FANG, Zhanggui WANG, Daoping ZHOU

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (8) : 63-68.

PDF(528 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (8) : 63-68. DOI: 10.3969/j.issn.1672-3384.2024.08.012

Original Article

Clinical efficacy of immune checkpoint inhibitors combined with anlotinib in the treatment of advanced non-small cell lung cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(8): 63-68 https://doi.org/10.3969/j.issn.1672-3384.2024.08.012

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(528 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2024-04-11	2024-08-20
Issue Date
2024-09-29

Please choose a citation manager

Content to export